EP3057595
Samrunnin bensasepín til meðferðar á stami
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.10.2014EP published:
29.4.2020EP application number:
14854586.6
EP translation filed:
29.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
16.10.2034Expiry date:
16.10.2026Next due date:
31.10.2026
Title:
FUSED BENZAZEPINES FOR TREATMENT OF STUTTERING
Timeline
Today
17.10.2014EP application
29.4.2020EP Publication
29.7.2020Translation submitted
15.8.2020Registration published
16.10.2026Expires
Owner
Name:
Emalex Biosciences, Inc.Address:
330 N Wabash, Suite 3500, Chicago, IL 60611, US
Inventor
Name:
CHIPKIN, Richard E.Address:
Bethesda, Maryland 20814, US
Agent
Name:
Greg SachAddress:
c/o Caya 83713X Am Börstig 5, DE
Priority
Number:
201361892841 PDate:
18.10.2013Country:
US
Classification
Categories:
A61K 31/55, A61P 25/14, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.9.2020
Expires: 16.10.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 27.9.2021
Expires: 16.10.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2022
Expires: 16.10.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.10.2023
Expires: 16.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.9.2024
Expires: 16.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 8.10.2025
Expires: 16.10.2026
Payer: Árnason Faktor ehf.